{
    "title": "U.S. FDA to restrict use of Regeneron, Lilly COVID antibody drugs - WaPo",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10436649/U-S-FDA-restrict-use-Regeneron-Lilly-COVID-antibody-drugs--WaPo.html",
    "date": "2022-01-24",
    "keywords": [
        "drug",
        "use",
        "variant",
        "administration",
        "fda",
        "covid19",
        "antibody",
        "regeneron",
        "omicron",
        "emergency",
        "report",
        "health",
        "comment",
        "december",
        "vir",
        "jan",
        "food",
        "washington",
        "post",
        "monday",
        "action",
        "agency",
        "case",
        "work",
        "spokesperson",
        "regulator",
        "communication",
        "topic",
        "statement",
        "candidate",
        "bebtelovimab",
        "activity",
        "concern",
        "government",
        "distribution",
        "halt",
        "efficacy",
        "strain",
        "glaxosmithkline",
        "biotechnologys",
        "sotrovimab",
        "gsk",
        "biotech",
        "production",
        "demand",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}